Iconovo AB, a company specializing in inhalable medications created with unique inhalers and dry powder formulations, has partnered with Lonza, a healthcare development and manufacturing firm, to develop spray-dried formulations of an intranasal...
Newron Pharmaceuticals S.p.A, a biopharmaceutical firm dedicated to creating innovative treatments for disorders of the central and peripheral nervous systems, along with Myung In Pharm Co. Ltd. (Myung In Pharm), the foremost CNS-focused...
Pharmaceutical firm Lupin Ltd has stated that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Pithampur Unit-1 manufacturing facility, which produces both APIs and...
India's pharmaceutical industry plans to increase its size to over USD 120-130 billion by 2030, leveraging innovation to establish itself as the global healthcare guardian, according to Samir Mehta, president of the Indian Pharmaceutical Alliance...
India's pharmaceutical industry is expected to show strong earnings growth of 19.4% year-over-year for the October-December quarter (Q3 FY25), fueled by solid domestic formulation (DF) sales, specialized US generic launches, and lower raw material...
The Subject Expert Committee (SEC) operating under the Central Drug Standard Control Organisation (CDSCO) has permitted drug giant Sun Pharma Laboratories to produce and sell Fexuprazan Hydrochloride Tablets 40 mg. Nonetheless, this approval is...
Innovent Biologics, a top-tier biopharmaceutical firm focused on creating, producing, and marketing high-quality drugs for oncology, cardiovascular and metabolic diseases, autoimmune disorders, ophthalmology, and various other serious illnesses...
Akums Drugs and Pharmaceuticals revealed the launch of a new sterile facility focused on manufacturing lyophilised products and injectables, alongside vials, ampoules, eye and ear drops, and form-fill-seal (FFS) products. Lyophilisation involves...
India now represents 60% of worldwide vaccine production and hosts the second-highest number of USFDA-approved manufacturing facilities outside the United States. As investment prospects expand in areas like Bio-Pharma, Bio-Agri, Bio-Industrial...
Indian pharmaceutical firms have achieved significant progress in complying with rigorous US Food and Drug Administration (USFDA) standards in 2024, with evidence indicating a reduction in adverse classification results from inspections involving...
, CDSCO.jpg)
